+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

US Influenza Market and Competitive Landscape - 2019

  • ID: 4790570
  • Report
  • May 2019
  • Region: United States
  • Fore Pharma
1 of 2
The latest research, US Influenza Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Influenza pipeline products, Influenza epidemiology, Influenza market valuations and forecast, Influenza drugs sales and competitive landscape in the US.

The research is classified into seven sections- Influenza treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:
  • Influenza pipeline: Find out the products in clinical trials for the treatment of Influenza by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Influenza epidemiology: Find out the number of patients diagnosed (prevalence) with Influenza in the US
  • Influenza drugs: Identify key products marketed and prescribed for Influenza in the US, including trade name, molecule name, and company
  • Influenza drugs sales: Find out the sales revenues of Influenza drugs in the US
  • Influenza market valuations: Find out the market size for Influenza drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Influenza drugs market share: Find out the market shares for key Influenza drugs in the US
Benefits of this Research:

The research helps executives to
  • Support monitoring and reporting national Influenza market analysis and sales trends
  • Track competitor drugs sales and market share in the US Influenza market
  • Track competitive developments in Influenza market and present key issues and learnings
  • Synthesize insights for Influenza market and products to drive business performance
  • Answer key business questions about the Influenza market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Influenza products
  • Supports decision making in R&D to long term marketing strategies

Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 2
1) Influenza Treatments
2) Influenza Pipeline
3) US Influenza Epidemiology
4) Marketed Drugs for Influenza in US
5) US Influenza Market Size and Forecast
6) US Influenza Products Sales and Forecast
7) US Influenza Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables
1. Influenza Phase 3 Clinical Trials, 2019
2. Influenza Phase 2 Clinical Trials, 2019
3. Influenza Phase 1 Clinical Trials, 2019
4. Influenza Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Influenza, US, 2018
6. Influenza Market Size and Forecast ($), US, 2014 – 2024
7. Influenza Product Sales ($), US, 2014 – 2024

List of Figures
1. Influenza Epidemiology, US, 2014 - 2024
2. Influenza Market Size and Forecast ($), US, 2014 – 2024
3. Influenza Products Market Share (%), US, 2018
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll